- Home
- EXPI vs CLDX Comparison
EXPI vs CLDX Comparison
Compare EXPI & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXPI
- CLDX
- Stock Information
- Founded
- EXPI 2008
- CLDX N/A
- Country
- EXPI United States
- CLDX United States
- Employees
- EXPI N/A
- CLDX N/A
- Industry
- EXPI Real Estate
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- EXPI Finance
- CLDX Health Care
- Exchange
- EXPI Nasdaq
- CLDX Nasdaq
- Market Cap
- EXPI 1.6B
- CLDX 1.6B
- IPO Year
- EXPI N/A
- CLDX 2008
- Fundamental
- Price
- EXPI $11.15
- CLDX $24.45
- Analyst Decision
- EXPI Strong Buy
- CLDX Strong Buy
- Analyst Count
- EXPI 1
- CLDX 9
- Target Price
- EXPI $12.00
- CLDX $46.13
- AVG Volume (30 Days)
- EXPI 963.7K
- CLDX 1.6M
- Earning Date
- EXPI 11-06-2025
- CLDX 11-05-2025
- Dividend Yield
- EXPI N/A
- CLDX N/A
- EPS Growth
- EXPI N/A
- CLDX N/A
- EPS
- EXPI N/A
- CLDX N/A
- Revenue
- EXPI $4,593,157,000.00
- CLDX $5,790,000.00
- Revenue This Year
- EXPI $3.60
- CLDX N/A
- Revenue Next Year
- EXPI $4.71
- CLDX N/A
- P/E Ratio
- EXPI N/A
- CLDX N/A
- Revenue Growth
- EXPI 3.62
- CLDX N/A
- 52 Week Low
- EXPI $6.90
- CLDX $14.40
- 52 Week High
- EXPI $15.39
- CLDX $47.00
- Technical
- Relative Strength Index (RSI)
- EXPI 57.41
- CLDX 57.32
- Support Level
- EXPI $10.91
- CLDX $22.44
- Resistance Level
- EXPI $11.70
- CLDX $25.51
- Average True Range (ATR)
- EXPI 0.34
- CLDX 1.22
- MACD
- EXPI 0.03
- CLDX 0.23
- Stochastic Oscillator
- EXPI 55.82
- CLDX 74.58
About EXPI eXp World Holdings Inc.
eXp World Holdings Inc is a cloud-based residential real estate company. The company owns and operates a cloud-based real estate brokerage and a technology platform business that develops and uses immersive technologies that help businesses increase their effectiveness and reduce costs from operating in traditional brick-and-mortar office spaces. Its business categories include Real Estate Brokerage, Technology Products and Services, Title, Escrow, Settlement Services, and Mortgage Brokerage Services. The company mainly operates in the United States and Canada, and it also has operations in the United Kingdom, Australia, South Africa, France, India, Portugal, and Mexico, among others.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.